Tyra Biosciences (TYRA) Interest Coverage Ratio (2020 - 2026)
Tyra Biosciences (TYRA) posted Interest Coverage Ratio of 0.13 for Q1 2026, up 99.93% on a QoQ basis from 182.58 in Q4 2025, and up 94.53% year-over-year from 0.07 in Q1 2025.
Tyra Biosciences (TYRA) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Tyra Biosciences' Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 0.13 for Q1 2026.
- Quarterly Interest Coverage Ratio rose 94.53% year-over-year to 0.13 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.44 (up 94.78% YoY) and the FY2025 annual result came in at 0.71, up 76.93% from the prior year.
- Interest Coverage Ratio was 0.13 for Q1 2026 at Tyra Biosciences, up from 182.58 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.13 in Q1 2026 and bottomed at 182.58 in Q4 2025.
- A 5-year average of 38.28 and a median of 0.72 in 2022 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio soared 99.84% — and 2025, when it tumbled 502.29%.
- Tyra Biosciences' Interest Coverage Ratio stood at 150.18 in 2022, then jumped by 99.6% to 0.6 in 2023, then tumbled by 16440.86% to 99.15 in 2024, then sank by 84.15% to 182.58 in 2025, then surged by 99.93% to 0.13 in 2026.
- Business Quant data shows TYRA's Interest Coverage Ratio at 0.13 in Q1 2026, 182.58 in Q4 2025, and 0.72 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Tyra Biosciences | 1.90 Bn | 1.90 Bn | - | -0.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.13 |
| Dec 31, 2025 | -182.58 |
| Sep 30, 2025 | -0.72 |
| Jun 30, 2025 | -2.28 |
| Mar 31, 2025 | -2.37 |
| Dec 31, 2024 | -99.15 |
| Sep 30, 2024 | -0.26 |
| Jun 30, 2024 | -0.47 |
| Mar 31, 2024 | -0.39 |
| Sep 30, 2023 | -0.60 |
| Jun 30, 2023 | -0.28 |
| Mar 31, 2023 | -0.26 |
| Dec 31, 2022 | -150.18 |
| Sep 30, 2022 | -0.73 |
| Jun 30, 2022 | -171.42 |
| Mar 31, 2022 | -0.74 |
| Sep 30, 2021 | -0.17 |
| Jun 30, 2021 | -55.08 |
| Mar 31, 2021 | -42.11 |
| Dec 31, 2020 | -612.83 |